BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30179911)

  • 1. Accumulation of 131I in Esophageal Diverticulum Diagnosed by SPECT/CT.
    Rizzo A; Zagaria L; Perotti G; Annunziata S; Salvatori M
    Clin Nucl Med; 2018 Nov; 43(11):e410-e411. PubMed ID: 30179911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I Whole-Body Scan Incidental Uptake Due to Spermatocele.
    Albano D; Motta F; Baronchelli C; Lucchini S; Bertagna F
    Clin Nucl Med; 2017 Nov; 42(11):901-904. PubMed ID: 28902733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer.
    Zhou H; Yan J; Huang R; Li L
    Clin Nucl Med; 2018 Jan; 43(1):e31-e32. PubMed ID: 29076899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
    Wisotzki C; Friese M; Ehresmann J; Derlin T
    Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake Within Achilles Tendon on Posttherapy Radioiodine Whole-Body Scan Related to Gouty Tophus.
    Ehrhart M; Tulchinsky M; Blacklock LC; Elojeimy S
    Clin Nucl Med; 2020 Aug; 45(8):e370-e372. PubMed ID: 32520497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Diagnostic
    Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
    J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
    Patel DR; Kamat BH; Farwell MD
    Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
    Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
    J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
    Rosario PW; Mourão GF; dos Santos JB; Calsolari MR
    Thyroid; 2014 Mar; 24(3):533-6. PubMed ID: 24067080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-Positive Uptake of Radioiodine in Renal Hamartoma in a Patient With Differentiated Thyroid Cancer.
    Shen G; Qi Z; Huang R; Liu B; Kuang A
    Clin Nucl Med; 2017 Sep; 42(9):709-710. PubMed ID: 28650888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Wu X; Gu H; Gao Y; Li B; Fan R
    Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic Uterine Uptake of Radioiodine During Menstruation Demonstrated by SPECT/CT.
    Liu L; Chen Y; Tian T; Huang R; Liu B
    Clin Nucl Med; 2019 Dec; 44(12):975-977. PubMed ID: 31361649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-Positive 131I Uptake in a Benign Bone Lesion on Post-therapy Scan.
    Yazici B; Oral A; Eraslan C; Argin M; Ömür Ö
    Clin Nucl Med; 2016 Jan; 41(1):e63-5. PubMed ID: 26252335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine accumulation in a large adnexal cystadenofibroma.
    Turker O; Dogan I; Kumanlioglu K
    Thyroid; 2010 May; 20(5):561-2. PubMed ID: 20406107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
    Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E
    Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 20. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
    Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
    Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.